[go: up one dir, main page]

BRPI0409930A - cristais de solvato derivado do ácido quinolinacarboxìlico - Google Patents

cristais de solvato derivado do ácido quinolinacarboxìlico

Info

Publication number
BRPI0409930A
BRPI0409930A BRPI0409930-3A BRPI0409930A BRPI0409930A BR PI0409930 A BRPI0409930 A BR PI0409930A BR PI0409930 A BRPI0409930 A BR PI0409930A BR PI0409930 A BRPI0409930 A BR PI0409930A
Authority
BR
Brazil
Prior art keywords
methyl
crystal
oxo
compound
acid
Prior art date
Application number
BRPI0409930-3A
Other languages
English (en)
Inventor
Jun Akai
Hiroshi Nishida
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of BRPI0409930A publication Critical patent/BRPI0409930A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"CRISTAIS DE SOLVATO DERIVADO DO áCIDO QUINOLINACARBOXìLICO". Um principal objetivo é fornecer um cristal de solvato em acetonitrila do ácido 6-flúor-1-metil-7-¢4-(5-metil-2-oxo-1,3-dioxolen-4-il)-metil-1piperazinil!- 4-oxo-4H-¢1,3! tiazeto ¢3,2-a! quinolina-3-carboxílico (Composto B), que é um intermediário para produzir preferencialmente o cristal do tipo III do ácido 6-flúor-1-metil-7-¢4-(5-metil-2-oxo-1,3-dioxolen-4-il)-metil-1-piperazinil!- 4-oxo-4H-¢1,3! tiazeto ¢3,2-a! quinolina-3-carboxílico (Composto A). Um cristal de Composto B pode ser precipitado preferencialmente por controle da concentração de supersaturação em cristalização usando-se acetonitrila como um solvente. Subseqüentemente, o cristal do tipo III de Composto A pode ser produzido por realização de dissolvatação do cristal.
BRPI0409930-3A 2003-04-30 2004-04-28 cristais de solvato derivado do ácido quinolinacarboxìlico BRPI0409930A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2003124643 2003-04-30
JP2004006057 2004-01-13
PCT/JP2004/006216 WO2004096815A1 (ja) 2003-04-30 2004-04-28 キノリンカルボン酸誘導体溶媒和物の結晶

Publications (1)

Publication Number Publication Date
BRPI0409930A true BRPI0409930A (pt) 2006-04-25

Family

ID=33422075

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0409930-3A BRPI0409930A (pt) 2003-04-30 2004-04-28 cristais de solvato derivado do ácido quinolinacarboxìlico

Country Status (13)

Country Link
US (1) US7612205B2 (pt)
EP (2) EP2354144A1 (pt)
JP (1) JP4655930B2 (pt)
KR (1) KR101088988B1 (pt)
AU (2) AU2004234287A1 (pt)
BR (1) BRPI0409930A (pt)
CA (1) CA2523854C (pt)
ES (1) ES2388921T3 (pt)
MX (1) MXPA05011525A (pt)
PL (1) PL1626051T3 (pt)
PT (1) PT1626051E (pt)
RU (1) RU2335503C2 (pt)
WO (1) WO2004096815A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012001357A1 (en) 2010-06-30 2012-01-05 Cipla Limited Crystalline form of prulifloxacin and processes for its preparation
RU2484768C1 (ru) * 2012-02-07 2013-06-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежская государственная медицинская академия им. Н.Н. Бурденко" Министерства здравоохранения и социального развития Российской Федерации Способ прогнозирования течения глаукомной оптической нейропатии
JP2021519334A (ja) 2018-03-26 2021-08-10 クリア クリーク バイオ, インコーポレイテッド ジヒドロオロト酸デヒドロゲナーゼを阻害するための組成物および方法
US20210300873A1 (en) 2020-03-20 2021-09-30 Clear Creek Bio, Inc. Stable polymorphic compositions of brequinar sodium and methods of use and manufacture thereof
JP2023518419A (ja) * 2020-03-20 2023-05-01 クリア クリーク バイオ, インコーポレイテッド ブレキナルナトリウムの安定した多形性組成物ならびにその使用および製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0751579B2 (ja) * 1987-11-07 1995-06-05 日本新薬株式会社 キノリンカルボン酸誘導体
SU1558915A1 (ru) * 1988-07-29 1990-04-23 Пермский фармацевтический институт 2-(5 @ -Нитрофурил)-2,3-дигидро-5Н-1,3,4-тиадиазоло[2,3-в]-хиназолинон-5, про вл ющий противомикробную активность

Also Published As

Publication number Publication date
EP2354144A1 (en) 2011-08-10
ES2388921T3 (es) 2012-10-19
MXPA05011525A (es) 2005-12-12
AU2010201309B2 (en) 2011-10-13
EP1626051A4 (en) 2008-06-25
RU2335503C2 (ru) 2008-10-10
AU2004234287A1 (en) 2004-11-11
PL1626051T3 (pl) 2012-10-31
JP4655930B2 (ja) 2011-03-23
KR101088988B1 (ko) 2011-12-01
US7612205B2 (en) 2009-11-03
EP1626051B1 (en) 2012-06-13
CA2523854A1 (en) 2004-11-11
WO2004096815A1 (ja) 2004-11-11
JPWO2004096815A1 (ja) 2006-07-13
KR20060008930A (ko) 2006-01-27
PT1626051E (pt) 2012-08-01
EP1626051A1 (en) 2006-02-15
CA2523854C (en) 2012-10-16
US20070149540A1 (en) 2007-06-28
RU2005137156A (ru) 2006-06-10
AU2010201309A1 (en) 2010-04-22

Similar Documents

Publication Publication Date Title
AR068527A2 (es) Un procedimiento para preparar monohidrato de bromuro de tiotropio cristalino
BR0213025A (pt) Compostos de espiro-hidantoìna úteis como agentes antiinflamatórios
AR073348A1 (es) Inhibidores ciclicos de 11 beta-hidroxiesteroide deshidrogenasa 1
PE20071325A1 (es) Derivados de n-heteroaril-carboxamidas triciclicas que contienen un resto bencimidazol, su preparacion y su aplicacion en terapeutica
PE20070706A1 (es) Nuevos derivados imidazopiridina como antagonistas de adenosina a2b
PE20140968A1 (es) Derivados de benzamida sustituida
PE20050700A1 (es) SAL DE ISETIONATO DE 6-ACETIL-8-CICLOPENTIL-5-METIL-2-(5-PIPERAZIN-1-IL-PIRIDIN-2-ILAMINO)-8H-PIRIDO[2,3-d]PIRIMIDIN-7-ONA COMO INHIBIDOR SELECTIVO DE CDK4
BR0313178A (pt) Derivados de pirazol e processo para a produção destes
NO20045403L (no) Nye tiofenamidiner, sammensetninger derav og fremgangsmater for behandling av komplementformidlede sykdommer og tilstander
CL2009000127A1 (es) Compuestos derivados de [indol, azaindol]-2-carboxamida sustituidos con un grupo silanilo; procedimiento de preparacion; compuestos intermediarios; composicion farmaceutica; y su uso en el tratamiento del dolor, inflamacion, trastornos metabolicos, entre otras enfermedades mediadas por la modulacion del receptor trpv1.
ECSP056016A (es) Nuevos derivados de 2-piridinacarboxamida
CO6501182A2 (es) Derivados de 1-heterociclil-1,5-dihidro-pirazolo[3,4-d]pirimidin-4-ona y su uso como moduladores de pde9a
AR107633A1 (es) Procedimiento para la preparación del ácido 4-fenil-5-alcoxicarbonil-2-tiazol-2-il-1,4-dihidropirimidin-6-il-[metil]-3-oxo-5,6,8,8a-tetrahidro-1h-imidazo[1,5a]pirazin-2-il-carboxílico
AR058287A1 (es) Derivados de isoquinolina y composicion farmaceutica
UY28724A1 (es) Derivados de sulfonamida para el tratamiento de enfermedades
AR045388A1 (es) Inhibidores del c-kit imidazopiridinicos n3-sustituidos
BRPI0409930A (pt) cristais de solvato derivado do ácido quinolinacarboxìlico
ECSP066542A (es) Derivados de disulfuro, sulfuro, sulfóxido, y sulfota de azúcares cíclicos y sus usos
NO20055632L (no) Aromatiske oksyfenyl- og aromatiske sulfanylfenylderivater
AR059896A1 (es) Derivados estereoisomericos de tetrahidronaftaleno, metodo de preparacion, medicamentos que los contienen, y uso como agentes antiinflamatorios.
GT200500281A (es) Compuestos organicos.
PE20040605A1 (es) Nuevas diamidas del acido pirimidin-4,6-dicarboxilico para la inhibicion selectiva de colagenesas
NO20090332L (no) 4-amino-3-arylamino-6-arylpyrazol[3,4-D]pyrimidinderivater, fremgangsmater for deres fremstilling og dere anvendelse som antivirale midler
DE60329189D1 (de) Pyrrolidinderivate als oxytocin antagonisten
BR112017022505A2 (pt) sal de sódio de inibidor de transportador de ácido úrico e forma cristalina do mesmo

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]